Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?
Although is still controversial, Trastuzumab (Herceptin) can be of potential use in the treatment of prostate cancer overexpressing HER2, either alone or in combination with other drugs.